{"version":"company-facts.v1","source":"https://secwatch.observer","generated_at":"2026-06-08T08:17:49.955440+00:00","company":{"ticker":"CPMV","cik":836564,"company_name":"Mosaic ImmunoEngineering Inc."},"pagination":{"limit":100,"returned":4,"next_cursor":null},"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer","counterparties":{"contract_counterparty":[{"display_name":"Case Western Reserve University","detail":"license","count":1,"first_seen":"2024-03-28T23:59:59+00:00","last_seen":"2024-03-28T23:59:59+00:00","evidence_fact_ids":[64614]}]},"facts":[{"fact_type":"executive_change","fact_key":"63cd2d36c1","cik":836564,"ticker":"CPMV","company_name":"Mosaic ImmunoEngineering Inc.","filed_at":"2024-07-25T23:59:59+00:00","payload":{"action":"resigned","action_category":"departure","departure_tone":"routine","effective_date":"2024-07-23","interim":false,"role":"Director","role_category":"director","successor_name":null,"successor_named":false},"claim":"Carlton Johnson resigned as Director at Mosaic ImmunoEngineering Inc..","evidence_excerpt":"On July 23, 2024, Mr. Carlton Johnson notified the Board of Directors (the “Board”) of Mosaic ImmunoEngineering, Inc. (the “Company”) of his resignation from the Board effective immediately.","confidence":1.0,"filing_url":"https://secwatch.observer/filing/0001683168-24-005057","anchor_url":"https://secwatch.observer/filing/0001683168-24-005057#claim-63cd2d36c1","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/836564/000168316824005057/0001683168-24-005057-index.htm"},{"fact_type":"executive_change","fact_key":"4ae259bb50","cik":836564,"ticker":"CPMV","company_name":"Mosaic ImmunoEngineering Inc.","filed_at":"2024-05-31T23:59:59+00:00","payload":{"action":"amended","action_category":"role_change","departure_tone":"not_applicable","effective_date":"2024-06-01","interim":false,"role":"EVP, Chief Financial Officer","role_category":"cfo","successor_name":null,"successor_named":false},"claim":"Paul Lytle changed role as EVP, Chief Financial Officer at Mosaic ImmunoEngineering Inc..","evidence_excerpt":"Mr. Paul Lytle, EVP, Chief Financial Officer of the Company, agreed to amend Mr. Lytle’s employment terms from full time status to part time status, not to exceed eight (8) hours per month effective June 1, 2024","confidence":0.95,"filing_url":"https://secwatch.observer/filing/0001683168-24-003923","anchor_url":"https://secwatch.observer/filing/0001683168-24-003923#claim-4ae259bb50","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/836564/000168316824003923/0001683168-24-003923-index.htm"},{"fact_type":"executive_change","fact_key":"9419f2cba4","cik":836564,"ticker":"CPMV","company_name":"Mosaic ImmunoEngineering Inc.","filed_at":"2024-04-19T23:59:59+00:00","payload":{"action":"passed away","action_category":"departure","departure_tone":"not_applicable","effective_date":"2024-04-17","interim":false,"role":"Director","role_category":"director","successor_name":null,"successor_named":false},"claim":"Gloria Felcyn departed as Director at Mosaic ImmunoEngineering Inc..","evidence_excerpt":"Mosaic ImmunoEngineering, Inc. (the “Company”) is deeply saddened to announce that director Ms. Gloria Felcyn passed away on April 17, 2024.","confidence":1.0,"filing_url":"https://secwatch.observer/filing/0001683168-24-002534","anchor_url":"https://secwatch.observer/filing/0001683168-24-002534#claim-9419f2cba4","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/836564/000168316824002534/0001683168-24-002534-index.htm"},{"fact_type":"material_agreement","fact_key":"5f023ebc455ca45d294d0ba740812e7acf11429d","cik":836564,"ticker":"CPMV","company_name":"Mosaic ImmunoEngineering Inc.","filed_at":"2024-03-28T23:59:59+00:00","payload":{"action":"termination","agreement_name":"License Agreement","agreement_type":"license","counterparty":"Case Western Reserve University","effective_date":"2024-03-22","item_codes_triggered":["1.02"],"value_text":null},"claim":"Mosaic ImmunoEngineering Inc. terminated License Agreement with Case Western Reserve University (effective 2024-03-22).","evidence_excerpt":"on March 22, 2024, the Company received a letter of termination from CWRU terminating our Agreement effective immediately due to our financial default","confidence":0.9,"filing_url":"https://secwatch.observer/filing/0001683168-24-001813","anchor_url":"https://secwatch.observer/filing/0001683168-24-001813#claim-5f023ebc455ca45d294d0ba740812e7acf11429d","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/836564/000168316824001813/0001683168-24-001813-index.htm"}]}